Silvia von Karstedt


Affiliation: University of Cologne
Country: Germany


  1. Kretz A, Trauzold A, Hillenbrand A, Knippschild U, Henne Bruns D, von Karstedt S, et al. TRAILblazing Strategies for Cancer Treatment. Cancers (Basel). 2019;11: pubmed publisher
    ..Moreover, we provide an overview and outlook on innovative and promising future TRAIL-based therapeutic strategies. ..
  2. García Reyes B, Kretz A, Ruff J, von Karstedt S, Hillenbrand A, Knippschild U, et al. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2018;19: pubmed publisher
    ..Here, we review the current knowledge of CDK biology, its role in cancer and the therapeutic potential to target CDKs as a novel treatment strategy for PDAC. ..
  3. Kretz A, von Karstedt S, Hillenbrand A, Henne Bruns D, Knippschild U, Trauzold A, et al. Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy. Cancers (Basel). 2018;10: pubmed publisher
    ..In this review, we summarize the status quo of clinical studies involving TRAIL-R agonists for the treatment of pancreatic cancer and critically discuss the suitability of utilizing the TRAIL-TRAIL-R system for successful treatment. ..